Advertisement
Older men who receive androgen deprivation therapy for prostate cancer may be at increased risk of developing depression

Androgen Deprivation Tx for Prostate CA Tied to Depression

0
Researchers find 23 percent increased risk compared to men who received other treatments
Use of the word "breakthrough" in the U.S. Food and Drug Administration's expedited approval process could mislead doctors about the new drugs' actual benefits

Doctors Can Be Misled About FDA ‘Breakthrough’ Drug Designation

0
Many believe meds supported by stronger evidence than the law requires to achieve designation

Society of Interventional Radiology, April 2-7

0
The Society of Interventional Radiology's 39th Annual Meeting The annual meeting of the Society of Interventional Radiology was held from April 2 to...
A radical proposal has been suggested for eliminating all Veterans Affairs (VA) medical centers and outpatient facilities in the next 20 years

VA Commission on Care: Eliminate VA Medical Centers

0
Eight veterans organizations denounce document in letter to Commission Chairwoman
Wider excision margins in thick cutaneous melanoma cases do not improve locoregional recurrence or melanoma-specific survival

Excision Margins Don’t Impact Melanoma Recurrence, Survival

0
Although, sentinel lymph node involvement is tied to poor prognosis
Recommendations have been issued for the use of direct oral anticoagulants in obese patients; the guideline was published online March 22 in the Journal of Thrombosis and Haemostasis.

Guidance Issued on Use of Direct Oral Anticoagulants in Obese

0
DOAC use not recommended for patients with BMI >40 kg/m² and weight >120 kg
The U.S. Preventive Services Task Force recommends aspirin use for primary prevention of cardiovascular disease and colorectal cancer in certain adults aged 50 to 69 years

USPSTF: Aspirin Recommended for Some Aged 50 to 69 Years

0
Benefits for primary prevention of CVD, CRC for certain adults aged 50 to 69 years
Venclexta (venetoclax) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia characterized by a specific chromosomal abnormality

FDA Approves Venclexta for CLL With 17p Deletion

0
Drug sanctioned for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality
For women with nonserous epithelial ovarian cancer

Hormone Tx No Harm After Nonserous Epithelial Ovarian CA

0
For women aged younger than 55 years, hormone therapy linked to improved disease-free survival
Extended-release niacin is associated with progressive and reversible thrombocytopenia

Niacin-ER May Be Overlooked Cause of Thrombocytopenia

0
Researchers also note marked improvement in hemoglobin upon drug discontinuation in anemia